HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
DIDO1
death inducer-obliterator 1
Chromosome 20 · 20q13.33
NCBI Gene: 11083Ensembl: ENSG00000101191.18HGNC: HGNC:2680UniProt: Q9BTC0
134PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
RNA bindingprotein bindingnucleusapoptotic signaling pathwaymenopauseobesityAbnormality of the skeletal systemovernutrition
✦AI Summary

DIDO1 (death inducer-obliterator 1) is a multifunctional protein that regulates cell differentiation, apoptosis, and transcriptional processes. In embryonic stem cells, DIDO1 is a target of master pluripotency factors Oct4, Sox2, and Nanog, and functions to maintain self-renewal through feedback regulation of these factors 1. DIDO1 contains a SPOC domain that acts as a phosphoserine-binding module, enabling interaction with the RNA polymerase II C-terminal domain and bridging transcription machinery with co-transcriptional regulators including splicing and RNA modification factors 2. DIDO3, the largest isoform encoded by DIDO1, is essential for accurate mRNA splicing and transcription termination; its deletion causes hepatitis, testicular degeneration, and progressive ataxia in mice 3. Disease relevance: DIDO1 dysregulation contributes to multiple pathologies. Circular RNA-derived DIDO1 (circDIDO1) functions as a tumor suppressor in gastric cancer, inhibiting cell proliferation and metastasis through PARP1 and PRDX2 interaction 4. In melanoma, BMP-induced DIDO1 upregulation promotes tumor progression via Integrin αV signaling 5. DIDO1 expression correlates with esophageal squamous cell carcinoma progression depth 6. Serum anti-DIDO1 antibodies serve as predictive biomarkers for acute ischemic stroke risk 7. Additionally, dengue and Zika viruses exploit DIDO1 as a host factor necessary for viral replication through interaction with viral NS1 protein 8.

Sources cited
1
DIDO1 is a target of Oct4, Sox2, and Nanog that regulates ES cell self-renewal through feedback loops
PMID: 24347171
2
DIDO1 contains a SPOC domain that binds phosphorylated serine residues on RNA Pol II CTD and bridges transcription machinery with processing regulators
PMID: 36631525
3
DIDO3 isoform is necessary for mRNA splicing and transcription termination; its deletion causes hepatitis, testicular degeneration, and ataxia
PMID: 35672775
4
CircDIDO1 suppresses gastric cancer progression by encoding DIDO1-529aa protein and regulating PRDX2 stability
PMID: 34384442
5
BMP-induced DIDO1 upregulation promotes melanoma progression through Integrin αV signaling
PMID: 22469980
6
DIDO1 expression correlates with esophageal squamous cell carcinoma tumor depth of invasion
PMID: 30761474
7
Serum anti-DIDO1 antibodies are predictive biomarkers for acute ischemic stroke risk
PMID: 34103026
8
DIDO1 interacts with dengue virus NS1 and functions as a host factor necessary for dengue and Zika virus replication
PMID: 35652656
Disease Associationsⓘ20
menopauseOpen Targets
0.28Weak
obesityOpen Targets
0.26Weak
Abnormality of the skeletal systemOpen Targets
0.19Weak
overnutritionOpen Targets
0.19Weak
chronic bronchitisOpen Targets
0.11Weak
Blackfan-Diamond anemiaOpen Targets
0.06Suggestive
Beta-thalassemia - X-linked thrombocytopeniaOpen Targets
0.06Suggestive
beta-thalassemia-X-linked thrombocytopenia syndromeOpen Targets
0.06Suggestive
hereditary neutrophiliaOpen Targets
0.06Suggestive
acute erythroleukemiaOpen Targets
0.06Suggestive
Familial hemophagocytic lymphohistiocytosisOpen Targets
0.06Suggestive
dominant beta-thalassemiaOpen Targets
0.06Suggestive
hemolytic anemia due to diphosphoglycerate mutase deficiencyOpen Targets
0.06Suggestive
hemoglobin D diseaseOpen Targets
0.06Suggestive
Hemoglobin C - beta-thalassemiaOpen Targets
0.06Suggestive
hemoglobin C-beta-thalassemia syndromeOpen Targets
0.06Suggestive
erythroleukemia, familial, susceptibility toOpen Targets
0.06Suggestive
hemoglobin H diseaseOpen Targets
0.06Suggestive
dehydrated hereditary stomatocytosisOpen Targets
0.05Suggestive
hemoglobin E diseaseOpen Targets
0.05Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
H3-3BProtein interaction100%H3C13Protein interaction100%H3C12Protein interaction100%H3-5Protein interaction100%H3C1Protein interaction100%H3C3Protein interaction99%
Tissue Expression6 tissues
Ovary
100%
Lung
80%
Heart
66%
Liver
64%
Bone Marrow
61%
Brain
46%
Gene Interaction Network
Click a node to explore
DIDO1H3-3BH3C13H3C12H3-5H3C1H3C3
PROTEIN STRUCTURE
Preparing viewer…
PDB4L7X · 1.35 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.23Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.15 [0.10–0.23]
RankingsWhere DIDO1 stands among ~20K protein-coding genes
  • #3,456of 20,598
    Most Researched134 · top quartile
  • #668of 17,882
    Most Constrained (LOEUF)0.23 · top 5%
Genes detectedDIDO1
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability.
PMID: 34384442
Mol Cancer · 2021
1.00
2
Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.
PMID: 22469980
Oncogene · 2013
0.90
3
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
PMID: 34103026
BMC Med · 2021
0.80
4
Role of DIDO1 in Progression of Esophageal Squamous Cell Carcinoma.
PMID: 30761474
J Gastrointest Cancer · 2020
0.70
5
Hepatitis, testicular degeneration, and ataxia in DIDO3-deficient mice with altered mRNA processing.
PMID: 35672775
Cell Biosci · 2022
0.60